NCT00586469View on ClinicalTrials.gov

A Randomized Study to Compare the Safety and Immunogenicity of Fluviral® Made With New Versus Aged Bulk

PHASE4CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 14, 2007

Primary Completion Date

January 14, 2008

Study Completion Date

January 14, 2008

Conditions
Influenza Vaccines
Interventions
BIOLOGICAL

Fluviral

One dose, Intramuscular injection

Trial Locations (8)

V3K 3P4

GSK Investigational Site, Coquitlam

A0A 1G0

GSK Investigational Site, Bay Roberts

M1L 4S4

GSK Investigational Site, Toronto

M9W 4L6

GSK Investigational Site, Toronto

J8Y 6S8

GSK Investigational Site, Gatineau

G1W 4R4

GSK Investigational Site, Québec

J1H 1Z1

GSK Investigational Site, Sherbrooke

J1H 4J6

GSK Investigational Site, Sherbrooke

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY